Eagle Pharmaceuticals Inc Tangible Net Worth Ratio
Eagle Pharmaceuticals Inc tangible net worth ratio. Eagle Pharmaceuticals Inc (EGRX) has a Tangible Net Worth Ratio of 57.4% as of June 2023. This metric is calculated by deducting intangible assets ($107.41 Million) from net assets ($252.04 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore EGRX net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Eagle Pharmaceuticals Inc (2013–2022)
Tangible net worth ratio of Eagle Pharmaceuticals Inc from 2013 to 2022. This chart shows how Eagle Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 10 annual periods from 2013 to 2022. As of June 2023, the ratio stands at 57.4%, reflecting net assets of $252.04 Million with intangible assets of $107.41 Million USD. Check EGRX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Eagle Pharmaceuticals Inc Tangible Net Worth Ratio by Year (2013–2022)
Eagle Pharmaceuticals Inc tangible net worth ratio by year from 2013 to 2022. The table below presents the year-by-year Tangible Net Worth Ratio for Eagle Pharmaceuticals Inc from 2013 to 2022, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see EGRX market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 49.3% | $233.56 Million | $118.33 Million | $406.16 Million | ▼ -44.6 pp |
| 2021 | 94.0% | $176.45 Million | $10.67 Million | $253.73 Million | ▲ +0.9 pp |
| 2020 | 93.1% | $186.01 Million | $12.92 Million | $253.19 Million | ▲ +1.8 pp |
| 2019 | 91.3% | $179.17 Million | $15.58 Million | $254.55 Million | ▲ +2.6 pp |
| 2018 | 88.7% | $160.76 Million | $18.10 Million | $238.60 Million | ▲ +1.8 pp |
| 2017 | 87.0% | $179.14 Million | $23.32 Million | $270.06 Million | ▲ +8.6 pp |
| 2016 | 78.4% | $151.23 Million | $32.62 Million | $213.57 Million | ▼ -21.6 pp |
| 2015 | 100.0% | $90.34 Million | $0.00 | $124.61 Million | ▲ +100.8 pp |
| 2014 | -0.8% | $33.10 Million | $33.37 Million | $53.41 Million | ▼ -100.8 pp |
| 2013 | 100.0% | $2.05 Million | $0.00 | $18.10 Million | — |